Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells

Liang,Lei; Li,Qian; Huang,Li  Yong; Li,Da  Wei; Wang,Yu  Wei; Li,Xin  Xiang; Cai,San  Jun

doi:10.3892/ijo.2014.2451

Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells

Authors:
- Lei Liang
- Qian Li
- Li Yong Huang
- Da Wei Li
- Yu Wei Wang
- Xin Xiang Li
- San Jun Cai
View Affiliations

Affiliations: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China, Department of Anesthesiology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200032, P.R. China
Published online on: May 21, 2014 https://doi.org/10.3892/ijo.2014.2451
Pages: 659-666

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Rho GTPases control a wide range of cellular processes and contribute to tumor invasion and metastasis. As a regulator of Rho activity, ARHGDIA is aberrantly expressed in several types of tumors and plays different roles in the tumor process. To elucidate the role of ARHGDIA in HCC, we investigated the patterns of its expression, prognosis and clinical profiles in HCC. Functional assays were performed to investigate whether the alteration of ARHGDIA has an effect on cell growth, migration and invasion, as well as the status of Rho GTPases. We found that ARHGDIA was frequently downregulated in HCC and associated with tumor invasion and metastasis. Moreover, ARHGDIA was significantly associated with OS and TTR of HCC patients. Low level of ARHGDIA exhibited a decreased postoperative OS and a shorter TTR compared those with high levels. Functional assays showed that loss of ARHGDIA promoted HCC cell migration and invasion in vitro and lung metastasis formation in vivo. We found that loss of ARHGDIA significantly induced Rac1 and RhoA activation which may contribute to invasion and metastasis of HCC. In conclusion, the present study has identified loss of ARHGDIA contributed to the processes of hepatic tumorigenesis, in particular invasion and metastasis which may provide a potential therapeutic target for HCC.

View Figures

View References

1	Bosch FX, Ribes J, Díaz M and Cléries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology. 127(Suppl 1): S5–S16. 2004. View Article : Google Scholar : PubMed/NCBI
2	Portolani N, Coniglio A, Ghidoni S, et al: Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 243:229–235. 2006. View Article : Google Scholar : PubMed/NCBI
3	Bruix J, Boix L, Sala M and Llovet JM: Focus on hepatocellular carcinoma. Cancer Cell. 5:215–219. 2004. View Article : Google Scholar
4	Takai Y, Sasaki T and Matozaki T: Small GTP-binding proteins. Physiol Rev. 81:153–208. 2001.PubMed/NCBI
5	Fukumoto Y, Kaibuchi K, Hori Y, et al: Molecular cloning and characterization of a novel type of regulatory protein (GDI) for the rho proteins, ras p21-like small GTP-binding proteins. Oncogene. 5:1321–1328. 1990.PubMed/NCBI
6	Leonard D, Hart MJ, Platko JV, et al: The identification and characterization of a GDP-dissociation inhibitor (GDI) for the CDC42Hs protein. J Biol Chem. 267:22860–22868. 1992.PubMed/NCBI
7	Sun HC, Zhang W, Qin LX, et al: Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol. 47:684–690. 2007. View Article : Google Scholar
8	Gao Q, Qiu SJ, Fan J, et al: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 25:2586–2593. 2007. View Article : Google Scholar : PubMed/NCBI
9	Ellenbroek SI and Collard JG: Rho GTPases: functions and association with cancer. Clin Exp Metastasis. 24:657–672. 2007. View Article : Google Scholar : PubMed/NCBI
10	Harding MA and Theodorescu D: RhoGDI signaling provides targets for cancer therapy. Eur J Cancer. 46:1252–1259. 2010. View Article : Google Scholar : PubMed/NCBI
11	Jones MB, Krutzsch H, Shu H, et al: Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics. 2:76–84. 2002. View Article : Google Scholar : PubMed/NCBI
12	Zhao L, Wang H, Li J, Liu Y and Ding Y: Overexpression of Rho GDP-dissociation inhibitor α is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res. 7:3994–4003. 2008.
13	Zhao L, Wang H, Sun X and Ding Y: Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. FEBS J. 277:4195–4204. 2010. View Article : Google Scholar : PubMed/NCBI
14	Forget MA, Desrosiers RR, Del M, et al: The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis. 19:9–15. 2002. View Article : Google Scholar : PubMed/NCBI
15	Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K and Mansel RE: Prognostic value of rho GTPases and rhoguanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res. 9:6432–6440. 2003.PubMed/NCBI
16	Habets GG, Scholtes EH, Zuydgeest D, et al: Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell. 77:537–549. 1994. View Article : Google Scholar : PubMed/NCBI
17	Hordijk PL, ten Klooster JP, van der Kammen RA, et al: Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science. 278:1464–1466. 1997. View Article : Google Scholar : PubMed/NCBI
18	Turner SJ, Zhuang S, Zhang T, et al: Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors. Biochem Pharmacol. 75:405–413. 2008. View Article : Google Scholar : PubMed/NCBI
19	Shibata S, Nagase M, Yoshida S, et al: Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 14:1370–1376. 2008. View Article : Google Scholar : PubMed/NCBI
20	Gorovoy M, Neamu R, Niu J, et al: RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs. Circ Res. 101:50–58. 2007. View Article : Google Scholar : PubMed/NCBI
21	Wei L, Imanaka-Yoshida K, Wang L, et al: Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development. 129:1705–1714. 2002.PubMed/NCBI
22	Li XR, Ji F, Ouyang J, et al: Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol. 32:1130–1134. 2006. View Article : Google Scholar : PubMed/NCBI
23	Wang D, Dou K, Xiang H, et al: Involvement of RhoA in progression of human hepatocellular carcinoma. J Gastroenterol Hepatol. 22:1916–1920. 2007. View Article : Google Scholar : PubMed/NCBI
24	Fuku K, Tamura S, Wada A, et al: Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma. J Cancer Res Clin Oncol. 132:627–633. 2006. View Article : Google Scholar : PubMed/NCBI
25	Wu X, Chen H, Gao Q, et al: Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma. Mol Carcinog. 53:325–336. 2014. View Article : Google Scholar : PubMed/NCBI
26	Takenawa T and Suetsugu S: The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol. 8:37–48. 2007. View Article : Google Scholar : PubMed/NCBI
27	Lee TK, Man K, Ho JW, et al: Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target. Carcinogenesis. 26:681–687. 2005.PubMed/NCBI
28	Liu S, Yu M, He Y, et al: Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology. 47:1964–1973. 2008. View Article : Google Scholar : PubMed/NCBI
29	Chen L, Chan TH, Yuan YF, et al: CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest. 120:1178–1191. 2010. View Article : Google Scholar : PubMed/NCBI